GORE SEAMGUARD Bioabsorbable Staple Line Reinforcement
Mesh, Surgical, Absorbable, Staple Line Reinforcement. 510(k) K181940, from W. L. Gore & Associates, Inc. (Elkton, MD). Product code OXC, class 2.
As of Nov 19, 2026, K181940 is an FDA 510(k) held by W. L. Gore & Associates, Inc., substantially equivalent on Aug 17, 2018 after 29 days, with no recalls tied to it in FDA's recall database.
- Review time: 29 days
- Recalls: 0
- Cited as a predicate by: 1 device
GORE® SEAMGUARD® Bioabsorbable Staple Line Reinforcement is indicated for use in surgical procedures in which soft tissue transection or resection with staple line reinforcement is needed. It can be used for reinforcement of staple lines during hysterectomy, lung resection, liver resection, bladder reconstruction, bronchial, bariatric, colon, colorectal, esophagus, gastric, mesentery, pancreas…
- Gore Seamguard Bioabsorbable Staple Line Reinforcement MaterialK043056 · W. L. Gore & Associates, Inc. · Dec 22, 2004
- SureForm 60 and SureForm 60 ReloadsK173721 · Intuitive Surgical · Jul 5, 2018
- Standard Staple-Line Reinforcement (SSLR23)K231603 · Standard Bariatrics, Inc. · Oct 6, 2023
- ECHELON ENDOPATH Staple Line Reinforcement (ECH60R)K252906 · Ethicon Endo-Surgery, LLC · Jan 9, 2026
- Standard Staple-Line Reinforcement (SSLR23)K231603 · Standard Bariatrics, Inc. · Oct 6, 2023
- ECHELON ENDOPATH Staple Line ReinforcementK221343 · Ethicon Endo-Surgery, LLC · Sep 16, 2022
- NEOVEIL Staple Line ReinforcementK221487 · Gunze Limited · Aug 26, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Jul 19, 2018
- Review panel
- General, Plastic Surgery
- Regulation
- 21 CFR 878.3300
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files